- Home
- VCRE vs OPCH Comparison
VCRE vs OPCH Comparison
Compare VCRE & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCRE | OPCH |
|---|---|---|
| Founded | N/A | N/A |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | VCRE | OPCH |
|---|---|---|
| Price | $11.53 | $23.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $36.57 |
| AVG Volume (30 Days) | 3.1K | ★ 2.5M |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $81.69 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $10.50 | $18.01 |
| 52 Week High | $12.85 | $36.80 |
Technical Indicators
Market Signals| Indicator | VCRE | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 60.12 |
| Support Level | $11.00 | $20.75 |
| Resistance Level | $12.85 | $24.96 |
| Average True Range (ATR) | 0.31 | 0.82 |
| MACD | 0.06 | 0.20 |
| Stochastic Oscillator | 85.48 | 65.42 |
Price Performance
Historical ComparisonAbout VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.